During the past decade, AV Medical Ltd. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AV Medical Ltd." #1 collaborator was "Chugai" with 1 trials as a collaborator and "Exelixis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "AV Medical Ltd." are "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Carcinoma, Renal Cell" (1 trials). Many other conditions were trialed in "AV Medical Ltd." in a lesser frequency.

Most popular intervention types in "AV Medical Ltd." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Cabozantinib" (1 trials), "Crizotinib" (1 trials) and "Entrectinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "AV Medical Ltd." are 2 trials for "All" genders.

Currently, there are NaN active trials in "AV Medical Ltd.". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in AV Medical Ltd., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AV Medical Ltd., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".